Global Sepsis Diagnostics Market Driven by Increasing Prevalence of Bacterial Infections

Sepsis is a potentially fatal condition that occurs when the body's response to an infection causes tissue damage. When the body's infection-fighting processes activate, organs function poorly and abnormally. Sepsis can lead to septic shock, resulting in a significant drop in blood pressure that can cause severe organ damage and death. Sepsis diagnostics include instruments, lab tests, various technologies, and others that are used to diagnose sepsis by examining the patient for signs of infection or organ damage. The global sepsis diagnostics market is expanding due to factors such as the prevalence of the COVID-19 pandemic, an increase in geriatric population, a rise in the prevalence of bacterial infections such as tuberculosis, and increased regulatory approvals for technologically advanced sepsis diagnostics products. As a result, the global sepsis diagnostics market, which was valued at USD 0.65 billion in 2021, is projected to grow at a significant CAGR of 9.60% from 2022 to 2027, to reach USD 1.11 billion.

These are the latest findings of DelveInsight (Las Vegas, NV, USA), a market research firm.

One of the key drivers of the sepsis diagnostics market has been the COVID-19 pandemic. According to the World Health Organization (WHO) data published on 1 July 2022, there were 545,226,550 confirmed cases of COVID-19 across the world. COVID-19 has well-known effects on the respiratory system, with the majority of victims requiring hospitalization for pneumonia of various severity, although almost all other organ systems can be impacted. This is consistent with a mix of sepsis and direct viral invasion. Therefore, sepsis diagnosis is required to verify or check for signs of any infection or organ damage with the disease. Thus, the surge in COVID-19 pandemic cases has boosted the demand for sepsis diagnostics, and further increase in COVID-19 cases is expected to increase the demand for tools, reagents, and test kits for sepsis detection, resulting in growth of the sepsis diagnostics market.

Based on product type, the instruments & kits segment of the sepsis diagnostics market is expected to record a significant growth during the forecast period. Furthermore, the increased regulatory approvals for technologically advanced sepsis diagnostics products may boost the region's overall sepsis diagnostics market. North America is expected to dominate the global sepsis diagnostics market in 2021 and will continue to dominate the market throughout the forecast period due to rising prevalence of bacterial infections such as tuberculosis and increase in regulatory approvals for technologically-advanced sepsis diagnostics products.

Related Links:
DelveInsight 

Visit expo >

New

Gold Member

Rotavirus Test

Rotavirus Test - 30003 – 30073

Verification Panels for Assay Development & QC
Seroconversion Panels

New

Community-Acquired Pneumonia Test

RIDA UNITY CAP Bac

New

Anti-HHV-6 IgM Assay

anti-HHV-6 IgM ELISA (semiquant.)